Treatment alternatives for impotence

References

• Masters WH, Johnson VE. Human sexual inadequacy. Boston: Little, Brown, 1970
   Google Scholar
• Kaplan HS. The new sex therapy. New York: Brunner/Mazel, 1974
   Google Scholar
• Goldstein I. National Kidney Foundation seminar (1988). Quoted in Newsday 1988 May 3
   Google Scholar
• Munjack DJ, Kanno PH. Retarded ejaculation: a review. Arch Sex Behav 1979: 8(2): 139–50
   PubMed Web of Science ®Google Scholar
• Smith AD. Psychologic factors in the multidisciplinary evaluation and treatment of erectile dysfunction. Urol Clin North Am 1988: 15(1): 41–51
   PubMed Web of Science ®Google Scholar
• Kaplan HS, Kohn RN, Pomeroy WB, et al. Group treatment of premature ejaculation. In: LoPiccolo J, LoPiccolo L, eds. Handbook of sex therapy. New York: Plenum Press, 1978: 277
   Google Scholar
• Prescott RW, Johnston DG, Kendall-Taylor P, et al. Hyperprolactinaemia in men: response to bromocriptine therapy. Lancet 1982: 1(8266): 245–8
   PubMed Web of Science ®Google Scholar
• Chiodini P, Liuzzi A, Cozzi R, et al. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment. J Clin Endocrinol Metab 1981: 53(4): 737–43
   PubMed Web of Science ®Google Scholar
• Molitch ME, Elton RL, Blackwell RE, et al. Bromocriptine as primary therapy for prolactinsecreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 1985: 60(4): 698–705
   PubMed Web of Science ®Google Scholar
• Serri O, Rasio E, Beauregard H, et al. Recurrence of hypetprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med 1983: 309(5): 280–3
   PubMed Web of Science ®Google Scholar
• Morales A, Condra M, Owen JA, et al. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 1987: 137(6): 1168–72
   PubMed Web of Science ®Google Scholar
• Reid K, Surridge DH, Morales A, et al. Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet 1987: 2(8556): 421–3
   PubMed Web of Science ®Google Scholar
• Morley JE. Impotence in older men. Hosp Pract [Off] 1988: 23(4): 139–42, 145–6, 152–3 passim
   PubMed Web of Science ®Google Scholar
• Elist J, Jarman WD, Edson M. Evaluating medical treatment of impotence. Urology 1984: 23(4): 374–5
   PubMed Web of Science ®Google Scholar
• Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol 1987: 137(5): 829–36
   PubMed Web of Science ®Google Scholar
• Nelson RP. Nonoperative management of impotence. J Urol 1988: 139(1): 2–5
   PubMed Web of Science ®Google Scholar
• Carson CC 3d, Mino RD. Priapism associated with trazodone therapy. J Urol 1988: 139(2): 369–70
   PubMed Web of Science ®Google Scholar
• Sacerdote A, Liberson V, Grosovenor M, et al. Recovery from diabetic impotence during improved diabetic control and inositol supplementation unassociated with improvement in bulbocavernous reflex latency (DRG). Diabetes 1985: 34(Suppl 1): 204A
   Google Scholar
• Zorgniotti AW, Lefleur RS. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol 1985: 133(1): 39–41
   PubMed Web of Science ®Google Scholar
• Lee LM, Stevenson RW, Szasz G. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a aouble-blind comparison. J Urol 1989: 141(3): 549–50
   PubMed Web of Science ®Google Scholar
• Sarosdy MF, Hudnall CH, Erickson DR, et al. A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence. J Urol 1989: 141(3): 559–3
   Google Scholar
• Fournier GR Jr, Lue TF. Vasculogenic impotence: physiology, diagnosis and treatment. In: Stamey TA, ed. Monographs in urology 1988: 9(2): 20
   Google Scholar
• Padma-Nathan H, Payton TP, Goldstein I. Treatment for organic impotence: alternatives to the penile prosthesis. Houston: American Urological Assn, 1987 (AUA update series, pt II, lesson 12, vol 6)
   Google Scholar
• Stief CG, Bahren W, Gall H, et al. Functional evaluation of penile hemodynamics. J Urol 1988: 139(4): 734–7
   PubMed Web of Science ®Google Scholar
• Stackl W, Hassun R, Marberger M. Prostaglandin E1 (PGE-1): the ideal drug for intracavemous autoinjection. Presented before 83d Annual Meeting of American Urological Association. Boston: 1988 Jun
   Google Scholar
• Waldhauser M, Schramek P. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction. J Urol 1988: 140(3): 525–7
   PubMed Web of Science ®Google Scholar
• Virag R. Revascularization of the penis. In: Bennett AH, ed. Management of male impotence. International perspectives in urology. Vol 5. Baltimore: Williams & Wilkins, 1982: 219–33
   Google Scholar
• Flanigan DP, Sobinsky KR, Schuler JJ, et al. Internal iliac artery revascularization in the treatment of vasculogenic impotence. Arch Surg 1985: 120(3): 271–4
   PubMedGoogle Scholar
• Goldstein I. Arterial revascularization procedures. Semin Urol 1986: 4(4): 252–8
   PubMedGoogle Scholar
• Sharlip YD, Furlow WI. Overview of International Society for Impotence Research. Urology 1987: 30(3): 205–8
   Web of Science ®Google Scholar
• Michal V, Kramar R, Pospichal J, et al. [Direct arterial anastomosis of corpora cavernosa of penis in the therapy of erective impotence.] Rozhl Chir 1973: 52(9): 587–90 (Cze)
   PubMedGoogle Scholar
• Padma-Nathan H, Payton TP, Goldstein I. Treatment for organic impotence: alternatives to the penile prosthesis. Houston: American Urological Assn, 1987 (AUA update series, pt I and II)
   Google Scholar
• Goldstein I. Vasculogenic impotence. Probl Urol 1987: 1(3): 547–63
   Google Scholar
• Bennett AH, Rivard DJ, Blanc RP, et al. Reconstructive surgery for vasculogenic impotence. J Urol 1986: 136(3): 599–601
   PubMed Web of Science ®Google Scholar
• Virag R, Bennett AH, Shoukry K. Arterial and venous surgery for vasculogenic impotence: a combined French and American experience. (Abstr) J Urol 1989: 141 (289A)
   Google Scholar
• Valji K, Bookstein J. Commentary: percutaneous transluminal angioplasty in arteriogenic impotence. In: Whitehead ED, ed. Current operative urology. Philadelphia: JB Lippincott, 1989: 280–6
   Google Scholar
• Lewis RW Puyau FA. Procedures for decreasing venous drainage. Semin Urol 1986: 4(4): 263–72
   PubMedGoogle Scholar
• Bar-Moshe O, Vandendris M. Treatment of impotence due to perineal venous leakage by ligation of crura penis. J Urol 1988: 139(6): 1217–9
   PubMed Web of Science ®Google Scholar
• Passive soft tissue implant market in the U.S. Frost & Sullivan, 1988: 248, 252
   Google Scholar
• Whitehead ED. Impotence. Diabetes Forecast 1982: 35(4): 35–8
   Google Scholar
• Whitehead ED. Erectile impotence in the diabetic: evaluation and treatment. In: Serrano-Rios M, Lefebvre PJ, eds. Diabetes nineteen eighty-five. New York: Elsevier Science Publishing, 1986: 783
   Google Scholar
• Krane RJ. Overview: malleable penile prostheses, multicomponent inflatable penile prostheses, and unitary inflatable penile prostheses. In: Whitehead, ed,36 pp 271–4
   Google Scholar
• Scott FB. Urological prosthetics: the penile implant. State-of-the-art lecture. Presented before 82d Annual Meeting of the American Urological Association. Anaheim, CA: 1987 May
   Google Scholar
• Furlow WL. Inflatable penile prosthesis: Mayo Clinic experience with 175 patients. Urology 1979: 13(2): 166–71
   PubMed Web of Science ®Google Scholar
• Malloy TR, Wein AJ, Carpiniello VL. Improved mechanical survival with revised model inflatable penile prosthesis using rear-tip extenders. J Urol 1982: 128(3): 489–91
   PubMed Web of Science ®Google Scholar
• Scarzella GI. Cylinder reliability of inflatable penile prosthesis: experience with distensible and nondistensible cylinders in 325 patients. Urology 1988: 31(6): 486–9
   PubMed Web of Science ®Google Scholar
• Furlow WL, Motley RC. The inflatable penile prosthesis: clinical experience with a new controlled expansion cylinder. J Urol 1988: 139(5): 945–6
   PubMed Web of Science ®Google Scholar
• Gregory JG, Purcell MH. Scott's inflatable penile prosthesis: evaluation of mechanical survival in the series 700 model. J Urol 1987: 137(4): 676–7
   PubMed Web of Science ®Google Scholar
• Collins KP, Hackler RH. Complications of penile prostheses in the spinal cord injury population. J Urol 1988: 140(5): 984–5
   PubMed Web of Science ®Google Scholar
• Levinson K, Whitehead ED. OmniPhase penile prosthesis: delayed bilateral central cable breakage. J Urol 1989: 141(3): 618–9
   PubMed Web of Science ®Google Scholar
• Small MP. The Small-Carrion penile prosthesis. Urol Clin North Am 1978: 5(3): 549–62
   PubMed Web of Science ®Google Scholar
• Finney RP. The Finney-plexrod penile implant. In: Carlton CE Jr, ed. Controversies in urology. St Louis: Mosby-Year Book, 1989: 106–10
   Google Scholar
• Scott FB. Editor's comment: malleable and mechanical penile prostheses. In: Carlton, ed,52 pp 124–5
   Google Scholar
• Gerstenberger DL, Osborne D, Furlow WL. Inflatable penile prosthesis: follow-up study of patient-partner satisfaction. Urology 1979: 14(6): 583–7
   PubMed Web of Science ®Google Scholar
• Beutler LE, Scott FB, Katacan I, et al. Women's satisfaction with partners' penile implant: inflatable vs noninflatable prosthesis. Urology 1984: 24(6): 552–8
   PubMed Web of Science ®Google Scholar
• Kabalin JN, Kessler R. Five-year followup of the Scott inflatable penile prosthesis and comparison with semirigid penile prosthesis. J Urol 1988: 140(6): 1428–30
   PubMed Web of Science ®Google Scholar
• Nadig PW, Becker RA. A noninvasive device that will produce and maintain an erection-like state. In: Serrano-Rios, Lefebver, eds,41 p 788
   Google Scholar
• Marmar JL, DeBenedictis TJ, Praiss DE. The use of a vacuum constrictor device to augment a partial erection following an intracavernous injection. J Urol 1988: 140(5): 975–9
   PubMed Web of Science ®Google Scholar
• Moul JW, McLeod DG. Negative pressure devices in the explanted penile prosthesis population. J Urol 1989: 142(3): 729–31
   PubMed Web of Science ®Google Scholar
• Nadig PW, Ware JC, Blumoff R. Noninvasive device to produce and maintain an erection-like state. Urology 1986: 27(2): 126–31
   PubMed Web of Science ®Google Scholar
• Witherington R. Suction device therapy in the management of erectile impotence. Urol Clin North Am 1988: 15(1): 123–8
   PubMed Web of Science ®Google Scholar